Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 841
Aptamer sequence: GGCUUUCGGGCUUUCGGCAACAUCAGCCCCUCAGCC
Target unique ID: HTB-81
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_758 E3 Cell Prostate cancer cells 146 nM DPBS with Ca2+ and Mg2+ 29666232
Structure information of aptamer
Aptamer Sequence: GGCUUUCGGGCUUUCGGCAACAUCAGCCCCUCAGCC
The optimal secondary structure in dot-bracket notation: ((((...(((((............)))))...))))
The centroid secondary structure in dot-bracket notation: ((((...(((((............)))))...))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_758 Description E3
Aptamer chemistry RNA Length 36 nt
GC content 63.9% Molecular weight 11,412.78 Da
Molarity of 1 μg/μl solution 87.62 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence GGCUUUCGGGCUUUCGGCAACAUCAGCCCCUCAGCC
Applications Efficiently kills prostate cancer cells in vitro but does not affect normal prostate epithelial cells
Target information
Type Detail Type Detail
ATCC ID HTB-81 Cell name Prostate cancer cells
Category Human cells Organism Homo sapiens, human
Product type N/A Cell type N/A
Morphology epithelial Tissue Prostate
Disease Carcinoma Product format Frozen
Antigen expression Blood Type O; Rh+ Genes expressed N/A
Cell description DU 145 is a cell line with epithelial morphology that was isolated from the brain of a 69-year-old, White, male with prostate cancer. This cell line is suitable as a transfection host.
Application(s) 3D cell culture; Cancer research; Neuroscience
Activity data
Interaction ID 841
Target type Cell
Target unique ID HTB-81
Activity 146 nM
Binding Conditions/Buffer

DPBS with Ca2+ and Mg2+

Assay

E3 targets prostate cancer cells with nanomolar apparent affinity

PubMed ID 29666232
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_1288 RNA GGCGCACUGGCGCUGCGCCUUCGGGCGCCAAUCGUAGCGUGUCGGCGCC 55.10%
Apta_634 RNA GGUCUUACGUCGUUCGCGACUAUUGGGAGACC 52.78%
Apta_366 RNA GGUUAGAGGCGACGUCCCGGAAUCCGCGCCCAUUGCCCCC 52.50%
Apta_521 RNA GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC 52.50%
Apta_271 RNA CUGUCGAGCAUGCUCAGGGUAACGUAUAGUCAAGACACCUCAAGUGUAACU 50.98%
Apta_424 RNA UGCUAGUAUAUCGCACGGAUUUAAUCGCCGUAGAAAAGCAUGUCAAAGCCG 50.98%
Apta_426 RNA UGCCGCUAUAAUGCACGGAUUUAAUCGCCGUAGAAAAGCAUGUCAAAGCCG 50.98%
Apta_1143 RNA ACGAGUUGUCGCAUGUGCGGUUCAGUCUGGUCCUUCAGCACCGUACAACAA 50.98%
Apta_856 RNA UGGGCCGGAGGUUAGCUUGCCCAUGGCAAGCAGGGCGCCACGGACCCA 50.00%
Apta_270 RNA CUGUCGAACAUGCUGAGGGUAACGUACUGGCAAGCUCACCUCAGCGUAGCUAa 49.06%
Apta_132 RNA GGGAGGACGAUGCGGCGUUUCCUCUGGUUCGUCCCCAGACGACUCGCCCGA 49.02%
Apta_134 RNA GGGAGGACGAUGCGGGCCGUUGUUGUGUGCCGCCCCAGACGACUCGCCCGA 49.02%
Apta_135 RNA GGGAGGACGAUGCGGAUUCUGGUUACUGGCCGCCCCAGACGACUCGCCCGA 49.02%
Apta_315 RNA GGGAGGACGAUGCGGUCGUAUUAUCCGCUGCACGCCAGACGACUCGCCCGA 49.02%
Apta_425 RNA UGCCGCCAUAUCACACGGAUUUAAUCGCCGUAGAAAAGCAUGUCAAAGCCG 49.02%
Apta_859 RNA GGGAGUCUGAAGUCGGACUUGUUAUCAAUUCACUUCAGACU 48.78%
Apta_51 RNA GCCUUAGUAACGUGCUUUGAUGUCGAUUCGACAGGAGGC 48.72%
Apta_599 RNA GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC 48.28%
Apta_599 RNA GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC 48.28%
Apta_269 RNA AACGCUCAACGUCAGAAGGCAACGUAUAGGCAAGCACACUUCGACAUGAGGC 48.08%